All results

2 results for cabozantinib and nivolumab treating patients advanced recurrent metastatic

• Immunotherapy for Patients With Advanced Kidney Cancer, The PDIGREE Study

  This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and…

  Ages

  18 Years - N/A

  Sexes

  All

• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid

  This is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal…

  Ages

  18 Years - N/A

  Sexes

  All